Skip to Main Content

Paper Details

Combining a Universal Telomerase Based Cancer Vaccine With Ipilimumab in Patients With Metastatic Melanoma - Five-Year Follow Up of a Phase I/IIa Trial.
Front Immunol
16
2021
Author NameAffiliation
Daniel Vod??kInstitute for Cancer Research, Oslo University Hospital
Sigve NakkenInstitute for Cancer Research, Oslo University Hospital
Sigve NakkenUniversity of Oslo
Eivind HovigInstitute for Cancer Research, Oslo University Hospital
Eivind HovigCenter for Bioinformatics, University of Oslo
  • 1 - 5

Datasets

Release 1.2